These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 31253108

  • 1. Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia.
    Petersen CH, Mahmood B, Badsted C, Dahlby T, Rasmussen HB, Hansen MB, Bindslev N.
    BMC Cancer; 2019 Jun 28; 19(1):643. PubMed ID: 31253108
    [Abstract] [Full Text] [Related]

  • 2. Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.
    Feddersen UR, Hendel SK, Berner-Hansen MA, Jepps TA, Berner-Hansen M, Bindslev N.
    BMC Gastroenterol; 2022 May 12; 22(1):234. PubMed ID: 35549670
    [Abstract] [Full Text] [Related]

  • 3. Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients.
    Jensen TSR, Mahmood B, Damm MB, Backe MB, Dahllöf MS, Poulsen SS, Hansen MB, Bindslev N.
    BMC Gastroenterol; 2018 Feb 27; 18(1):31. PubMed ID: 29486731
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
    Kaltoft N, Tilotta MC, Witte AB, Osbak PS, Poulsen SS, Bindslev N, Hansen MB.
    BMC Gastroenterol; 2010 Jan 26; 10():9. PubMed ID: 20100359
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D, Fu L, Sun H, Guo L, DuBois RN.
    Gastroenterology; 2015 Dec 26; 149(7):1884-1895.e4. PubMed ID: 26261008
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ, Greenhough A, Ordóñez-Morán P, Talero E, Cherry CA, Wallam CA, Parry L, Al Kharusi M, Roberts HR, Mariadason JM, Clarke AR, Huelsken J, Williams AC, Paraskeva C.
    Gut; 2012 Sep 26; 61(9):1306-14. PubMed ID: 22082586
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p-21-Activated kinase 1 mediates gastrin-stimulated proliferation in the colorectal mucosa via multiple signaling pathways.
    Huynh N, Yim M, Chernoff J, Shulkes A, Baldwin GS, He H.
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar 15; 304(6):G561-7. PubMed ID: 23306081
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia.
    Mahmood B, Damm MM, Jensen TS, Backe MB, Dahllöf MS, Poulsen SS, Bindslev N, Hansen MB.
    BMC Cancer; 2016 Dec 07; 16(1):938. PubMed ID: 27927168
    [Abstract] [Full Text] [Related]

  • 11. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW, Lee BH, Suh YA, Choi YS, Jang SJ, Kim YM, Choi KY, Min DS.
    Clin Cancer Res; 2017 Dec 01; 23(23):7340-7350. PubMed ID: 28939743
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J, Xie N, Xie K, Zeng J, Cheng L, Lei Y, Liu Y, Song L, Dong D, Chen Y, Zeng R, Nice EC, Huang C, Wei Y.
    Carcinogenesis; 2013 Dec 01; 34(12):2861-9. PubMed ID: 23803691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. β-Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APC.
    Fredericks E, Dealtry G, Roux S.
    Can J Gastroenterol Hepatol; 2018 Dec 01; 2018():4379673. PubMed ID: 30186819
    [Abstract] [Full Text] [Related]

  • 16. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P, Jaén RI, Calle D, Gómez-Serrano M, Núñez E, Fernández-Velasco M, Martín-Sanz P, Alonso S, Vázquez J, Cerdán S, Peinado MÁ, Boscá L.
    World J Gastroenterol; 2019 Jan 28; 25(4):433-446. PubMed ID: 30700940
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC, Miao ZG, Li JY, Qiao ZB.
    Int J Clin Exp Pathol; 2015 Jan 28; 8(5):4481-91. PubMed ID: 26191138
    [Abstract] [Full Text] [Related]

  • 18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Zhang C, Huang B, Hu ZW.
    Gastroenterology; 2019 Feb 28; 156(3):708-721.e15. PubMed ID: 30365932
    [Abstract] [Full Text] [Related]

  • 19. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
    Dai L, King DW, Perera DS, Lubowski DZ, Burcher E, Liu L.
    Dig Dis Sci; 2015 May 28; 60(5):1236-46. PubMed ID: 25666316
    [Abstract] [Full Text] [Related]

  • 20. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
    Gustafsson A, Hansson E, Kressner U, Nordgren S, Andersson M, Wang W, Lönnroth C, Lundholm K.
    Int J Cancer; 2007 Jul 15; 121(2):232-40. PubMed ID: 17290397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.